Assessment of patient satisfaction after levonorgestral containing intrauterine system insertion in women with abnormal uterine bleeding
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20215095Keywords:
LNG-IUS, Abnormal uterine bleeding, GynecologyAbstract
Background: Abnormal uterine bleeding is a common gynecological complaint affecting 10-30% of reproductive-aged women and it can result from different causes which adversely affects the woman’s quality of life, necessitating its appropriate and adequate management. Among all the pharmacological and surgical management options of AUB. LNG-IUS is emerging as a safer and effective treatment option of AUB. However apprehension about discomfort associated with the use of intrauterine device leads to its untimely removal. Aim of current study was to conduct a prospective qualitative study to observe the level of patient satisfaction with the use of LNG-IUS in patients with abnormal uterine bleeding.
Methods: This study was conducted in the department of obstetrics and gynecology, MGM medical college and M.Y. Group of Hospitals, Indore from March 2017- March 2018. Follow up was done at 1, 3, 6 months.
Results: In our study, majority of the women (90%) had improvement in their abnormal uterine bleeding along with significant increase in mean hemoglobin level from7.30+1.29 gm% to 8.71+1.27 gm% at the end of six months. 86.66% of these patients were very satisfied with the use of LNG IUS,
Conclusions: LNG-IUS is an effective device for medical management of AUB and it should be used as the first line therapy for the same. It should always be considered before surgical interventions. It yields promising result in terms of patient satisfaction.
References
Cooper JM. Contemporary management of abnormal uterine bleeding. Preface. Obstet Gynecol Clin North Am. 2000;27:11 3.
Sharma A, Dogra Y. Trends of AUB in tertiary centre of Shimla hills. J Midlife Health. 2013;4:67-8.
Padubidri VG, Daftary SN. Shaw‘s textbook of gynaecology,16th ed. Netherlands: Elsevier; 2014.
Singh K, Prasad D, Bharati G, Kumari S. Role of levonorgestrel releasing intrauterine device in management of heavy menstrual bleeding: a conservative approach. Int J Reprod Contracept Obstet Gynecol. 2017;6:631-5.
Dhamangaonkar PC, Anuradha K, Saxena A. Levonorgestrel intrauterine system (Mirena): An emerging tool for conservative. J Midlife Health. 2015;6:45-9.
NICE guidelines for Heavy menstrual bleeding: assessment and management. Available at: https://www.nice.org.uk/guidance/ng88. Accessed on 20 August 2021.
Cim N, Soysal S, Sayan S, Yildizhan B, Karaman E, Cetin O, et al. Two years follow-up of patients with abnormal uterine bleeding after insertion of the levonorgestrel-releasing intrauterine system. Gynecol Obstet Invest. 2018;83(6):569-75.
Shulman LP, Nelson AL, Darney PD. Recent developments in hormone delivery systems. Am J Obstet Gynecol. 2004;190:39-48.
